France· FR:61253153
RUCONEST 2100 U, poudre et solvant pour solution injectable
A conestat alfa product containing conestat alfa, registered in France by PHARMING GROUP (PAYS-BAS). The same ATC class is registered in 11 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Conestat alfa is registered in 11 of 19 countries.
Countries holding a registration under ATC B06AC04 (conestat alfa), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 7 of them publish a price we can compare per daily dose
Conestat alfa · ATC B06AC04
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CONESTAT ALFA
- Manufacturer
- PHARMING GROUP (PAYS-BAS)
- Country
- France (FR)
- ATC code
- B06AC04
- ATC class
- Conestat alfa
- Defined daily dose
- 3.5 TSD, E
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009301429981 flacon de poudre en verre + 1 flacon de solvant en verre + 2 adaptateurs pour flacon + 1 seringue + 1 set de perfusion + 2 lingettes d’alcool +1 compresse stérile +1 pansement
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
47 interactions on record for conestat alfa.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Conestat alfa · interactions on record
47 records
- 5 severe
- 42 moderate
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- ThalidomideL04AX02severe
- LenalidomideL04AX04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Conestat alfa in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandBerinertCSL Behring GmbH
- ItalyBERINERT*1 flaconcino polv EV 1.500 UI + 1 flaconcino solv 3 ml + setCSL BEHRING GmbH
- SpainRUCONEST 2100 U POLVO PARA SOLUCION INYECTABLEPharming Group N.V.
- United KingdomRuconest 2,100unit powder and solvent for solution for injection vialsPharming Group N.V.
- IrelandRuconest 2100 Units powder and solvent for solution for injectionPharming Group N.V.
- IcelandRuconestPharming Group N.V.*
- BelgiumRuconest 2100 UPharming Group
- CzechiaRUCONESTPharming Group N.V., Leiden
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ruconest
- Liechtenstein · Ruconest
- Norway · Ruconest
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f38f219e-8075-4d45-a1e4-065c769893cc GET /v1/drugs/f38f219e-8075-4d45-a1e4-065c769893cc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61253153",
"date_amm": "2017-01-11",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/10/641",
"substance": "CONESTAT ALFA",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "poudre et solvant pour solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about conestat alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.